Correction to: Recommended Best Practices for Lyophilization Validation-2021 Part I: Process Design and Modeling
AAPS PharmSciTech
.
2021 Oct 18;22(8):250.
doi: 10.1208/s12249-021-02129-0.
Authors
Feroz Jameel
1
,
Alina Alexeenko
2
,
Akhilesh Bhambhani
3
,
Gregory Sacha
4
,
Tong Zhu
1
,
Serguei Tchessalov
5
,
Lokesh Kumar
6
,
Puneet Sharma
6
,
Ehab Moussa
1
,
Lavanya Iyer
7
,
Rui Fang
8
,
Jayasree Srinivasan
4
,
Ted Tharp
1
,
Joseph Azzarella
9
,
Petr Kazarin
10
,
Mehfouz Jalal
2
Affiliations
1
Abbvie, North Chicago, IL, USA.
2
Birck Nanotechnology Center, Purdue University, 1205 W State St, West Lafayette, IN, 47907, USA.
3
Ultragenyx pharmaceutical Inc, Brisbane, CA, USA.
4
Baxter Healthcare, Bloomington, IN, USA.
5
Pfizer, Andover, MA, USA.
6
Genentech, South San Francisco, CA, USA.
7
BMS, New Brunswick, NJ, USA.
8
Merck, Kenilworth, NJ, USA.
9
Fresenius Kabi, Buffalo, NY, USA.
10
Birck Nanotechnology Center, Purdue University, 1205 W State St, West Lafayette, IN, 47907, USA. pkazarin@purdue.edu.
PMID:
34664114
PMCID:
PMC9172785
DOI:
10.1208/s12249-021-02129-0
Abstract
Publication types
Published Erratum